APAP

DEVICE5 trials

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre, Fisher and Paykel Healthcare, Antonios Likourezos, University of Arizona, SleepRes Inc.

Conditions

Healthy Adult VolunteersInsomniaObstructive Sleep ApneaPain ManagementResistant Hypertension

Early Phase 1

4-methylpyrazole and Acetaminophen Metabolism

CompletedNCT03878693

University of ArizonaHealthy Adult Volunteers

Start: 2018-07-01End: 2018-10-31Updated: 2019-09-26

Phase 2

IBUPAP Study for Pain Management in Children

CompletedNCT03088800

Antonios LikourezosPain Management

Start: 2018-04-30End: 2020-07-30Updated: 2021-03-25

Unknown Phase

Effect of Continuous Positive Airway Pressure (CPAP) Versus Auto-titrating Continuous Positive Airway Pressure (APAP) on Resistant Hypertension (HTN) and Arterial Stiffness

McGill University Health Centre/Research Institute of the McGill University Health CentreObstructive Sleep Apnea, Resistant Hypertension

Start: 2009-12-31End: 2020-01-31Target: 34Updated: 2018-03-22

Evaluation of APAP With SensAwake in OSA and Insomnia Patients

CompletedNCT02721329

Fisher and Paykel HealthcareInsomnia, Obstructive Sleep Apnea

Start: 2016-06-30End: 2020-03-31Updated: 2020-07-02

KPAP Adherence Crossover Study

Not yet recruitingNCT06413134

SleepRes Inc.Obstructive Sleep Apnea

Start: 2026-07-01End: 2026-12-31Target: 30Updated: 2026-05-06

Related Papers

The Effect of 4-Methylpyrazole on Oxidative Metabolism of Acetaminophen in Human Volunteers.

2019-11-2553 citations

Combination of obstructive sleep apnoea and insomnia treated by continuous positive airway pressure with the SensAwake pressure relief technology to assist sleep: a randomised cross-over trial protocol.

2017-10-272 citations